The medical diagnostics company beat more than 210 startups, scaleups and SMEs from across the globe to take top spot in one of the world’s most established open innovation competitions for wearable and health technologies.
FluoretiQ’s success came after pitching in front of an international expert judging panel of leading institutions including Santander Bank, Hong Kong Science and Technology Parks Corporation, EY, The Chinese University of Hong Kong, The University of Cambridge, and STMicroelectronics.
Dr. Neciah Dorh, CEO and Co-Founder of FluoretiQ Limited, said: “The Hong Kong MedTech Innovation World Cup win is a major boost for us, and positions FluoretiQ as a leading voice in global MedTech innovation with a mission grounded firmly in improving outcomes for patients, and the clinical professionals who care for them. We are especially honoured to receive this award during the first Wearable Technologies Conference to be hosted in Hong Kong in 10 years.”
Held on 5 March at the Wearable Technologies Conference at Science Park, the Hong Kong MedTech Innovation World Cup is part of the Innovation World Cup Series, with more than 20 years of competition history.
A Bristol Success Story
Founded in 2017 as a spinout from the University of Bristol by alumni from the Department of Electrical and Electronic Engineering, FluoretiQ has grown at the centre of the South West’s life sciences and deep tech ecosystem. The company remains headquartered in Bristol and is an active collaborator with the University of Bristol.
The win at the Hong Kong MedTech Innovation World Cup 2026 is the latest in a series of milestones for the company.